Bee Vectoring Technologies International (TSE:BEE) has released an update.
Bee Vectoring Technologies (BVT) has announced a partnership with Syensqo to develop its biological control agent, CR-7, as a seed treatment for soybeans, aiming to accelerate market reach and address soil pests and diseases. Leveraging Syensqo’s expertise, BVT plans to commercialize CR-7 through established agricultural suppliers and distributors, with the agent already showing a 4% yield increase in US trials.
For further insights into TSE:BEE stock, check out TipRanks’ Stock Analysis page.
